Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Philippe Pibarot is active.

Publication


Featured researches published by Philippe Pibarot.


Circulation | 2010

Comparison Between Transcatheter and Surgical Prosthetic Valve Implantation in Patients With Severe Aortic Stenosis and Reduced Left Ventricular Ejection Fraction

Marie-Annick Clavel; John G. Webb; Josep Rodés-Cabau; Jean-Bernard Masson; Eric Dumont; R. De Larochellière; Daniel Doyle; Sébastien Bergeron; Helmut Baumgartner; Ian G. Burwash; Jean-Gaston Dumesnil; Gerald Mundigler; Robert Moss; Aleksander Kempny; Rodrigo Bagur; Jutta Bergler-Klein; Ronen Gurvitch; Patrick Mathieu; Philippe Pibarot

Background— Patients with severe aortic stenosis and reduced left ventricular ejection fraction (LVEF) have a poor prognosis with conservative therapy but a high operative mortality when treated surgically. Recently, transcatheter aortic valve implantation (TAVI) has emerged as an alternative to surgical aortic valve replacement (SAVR) for patients considered at high or prohibitive operative risk. The objective of this study was to compare TAVI and SAVR with respect to postoperative recovery of LVEF in patients with severe aortic stenosis and reduced LV systolic function. Methods and Results— Echocardiographic data were prospectively collected before and after the procedure in 200 patients undergoing SAVR and 83 patients undergoing TAVI for severe aortic stenosis (aortic valve area ≤1 cm2) with reduced LV systolic function (LVEF ≤50%). TAVI patients were significantly older (81±8 versus 70±10 years; P<0.0001) and had more comorbidities compared with SAVR patients. Despite similar baseline LVEF (34±11% versus 34±10%), TAVI patients had better recovery of LVEF compared with SAVR patients (&Dgr;LVEF, 14±15% versus 7±11%; P=0.005). At the 1-year follow-up, 58% of TAVI patients had a normalization of LVEF (>50%) as opposed to 20% in the SAVR group. On multivariable analysis, female gender (P=0.004), lower LVEF at baseline (P=0.005), absence of atrial fibrillation (P=0.01), TAVI (P=0.007), and larger increase in aortic valve area after the procedure (P=0.01) were independently associated with better recovery of LVEF. Conclusion— In patients with severe aortic stenosis and depressed LV systolic function, TAVI is associated with better LVEF recovery compared with SAVR. TAVI may provide an interesting alternative to SAVR in patients with depressed LV systolic function considered at high surgical risk.


Heart | 2005

Impact of systemic hypertension on the assessment of aortic stenosis

Lyes Kadem; Jean-Gaston Dumesnil; Régis Rieu; Louis-Gilles Durand; Damien Garcia; Philippe Pibarot

Objective: To determine the effect of systemic arterial hypertension on the indices of aortic stenosis (AS) severity. Methods: A severe supravalvar AS was created in 24 pigs. The maximum and mean pressure gradients across the stenosis were measured by Doppler echocardiography and by catheterisation. Both echocardiography and catheter data were used to calculate stenosis effective orifice area, energy loss coefficient, and peak systolic left ventricular wall stress. Measurements were taken both at normal aortic pressures and during hypertension induced by banding of the distal thoracic aorta in 14 pigs and by intravenous administration of phenylephrine in 10 pigs. Results: During hypertension, systemic arterial resistance downstream from the stenosis increased greatly (all animals: 71 (40)%), whereas total systemic arterial compliance decreased significantly (−38 (21)%). Hypertension resulted in a moderate increase in effective orifice area (29 (14)%) and energy loss coefficient (25 (17)%) and substantial decreases in catheter gradients (maximum: −40 (20)%; mean: −43 (20)%; peak to peak: −70 (23)%) and Doppler gradients (maximum: −35 (17)%; mean: −37 (16)%). In multivariate analysis, peak to peak gradient was significantly (p < 0.001) related to the energy loss coefficient, mean flow rate, and arterial compliance, whereas maximum and mean catheter gradients were related only to the energy loss coefficient and flow rate. Of major importance, maximum systolic left ventricular wall stress increased greatly during hypertension (43 (23)%). Conclusions: The severity of AS may be partially masked by the presence of coexisting hypertension. The markers of AS severity should thus be interpreted with caution in hypertensive patients and be re-evaluated when the patient is in a normotensive state.


Heart | 2002

A new, simple, and accurate method for non-invasive estimation of pulmonary arterial pressure

Xu J; Louis-Gilles Durand; Philippe Pibarot

Objective: To develop and validate a new non-invasive method for the estimation of pulmonary arterial pressure (PAP) based on advanced signal processing of the second heart sound. Design: Prospective comparative study. Setting: Referral cardiology centre. Patients: This method was first tested in 16 pigs with experimentally induced pulmonary hypertension and then in 23 patients undergoing pulmonary artery catheterisation. Methods: The heart sounds were recorded at the surface of the thorax using a microphone connected to a personal computer. The splitting time interval between the aortic and the pulmonary components of the second heart sound was measured using a computer assisted spectral dechirping method and was normalised for heart rate. Results: The systolic PAP varied between 14–73 mm Hg in pigs and between 20–70 mm Hg in patients. The normalised splitting interval was measurable in 97% of the recordings made in pigs and 91% of the recordings made in patients. There was a strong relation between the normalised splitting interval and the systolic PAP (pigs: r = 0.94, standard error of the estimate (SEE) = 5.3 mm Hg; patients: r = 0.84, SEE = 7.8 mm Hg) or the mean pulmonary pressure (pigs: r = 0.94, SEE = 4.1 mm Hg; patients: r = 0.85, SEE = 5.8 mm Hg). Conclusions: This study shows that this new non-invasive method based on advanced signal processing of the second heart sound provides an accurate estimation of the PAP.


Journal of Biomechanical Engineering-transactions of The Asme | 2010

In Vitro Investigation of the Impact of Aortic Valve Stenosis Severity on Left Coronary Artery Flow

Emmanuel Gaillard; Damien Garcia; Lyes Kadem; Philippe Pibarot; Louis-Gilles Durand

Patients with aortic valve stenosis (AS) may experience angina pectoris even if they have angiographically normal coronary arteries. Angina is associated with a marked increase in the risk of sudden death in AS patients. Only a few in vitro models describing the interaction between the left ventricular and aortic pressures, and the coronary circulation have been reported. These models were designed for specific research studies and they need to be improved or modified when other specific studies are required. Consequently, we have developed an in vitro model that is able to mimic the coronary circulation in presence of aortic stenosis. First, we have validated the model under physiological conditions. Then, we have examined and quantified the hemodynamic effects of different degrees of AS (from normal to severe AS) on the coronary flow using a model of the normal left coronary artery. In the coronary in vitro model without AS (normal valve), the amplitude and shape of coronary flow were similar to those observed in in vivo measurements obtained under physiological conditions, as described by Hozumi et al. (1998, Noninvasive Assessment of Significant Left Anterior Descending Coronary Artery Stenosis by Coronary Flow Velocity Reserve With Transthoracic Color Doppler Echocardiography, Circulation, 97, pp. 1557-1562). The presence of an AS induced an increase in the maximum and mean coronary flow rates (97% and 73%, respectively, for a very severe AS). Furthermore, when AS was very severe, a retrograde flow occurred during systole. This study allowed us to validate our coronary in vitro model under physiological conditions, both in the absence and presence of AS. These changes could explain the fact that even if patients have angiographically normal epicardial coronary arteries, we can observe the occurrence of angina pectoris in these patients in the presence of an AS.


Journal of Biomechanical Engineering-transactions of The Asme | 2013

On the evaluation of vorticity using cardiovascular magnetic resonance velocity measurements.

Julio Garcia; Eric Larose; Philippe Pibarot; Lyes Kadem

Vorticity and vortical structures play a fundamental role affecting the evaluation of energetic aspects (mainly left ventricle work) of cardiovascular function. Vorticity can be derived from cardiovascular magnetic resonance (CMR) imaging velocity measurements. However, several numerical schemes can be used to evaluate the vorticity field. The main objective of this work is to assess different numerical schemes used to evaluate the vorticity field derived from CMR velocity measurements. We compared the vorticity field obtained using direct differentiation schemes (eight-point circulation and Chapra) and derivate differentiation schemes (Richardson 4* and compact Richardson 4*) from a theoretical velocity field and in vivo CMR velocity measurements. In all cases, the effect of artificial spatial resolution up-sampling and signal-to-noise ratio (SNR) on vorticity computation was evaluated. Theoretical and in vivo results showed that the eight-point circulation method underestimated vorticity. Up-sampling evaluation showed that the artificial improvement of spatial resolution had no effect on mean absolute vorticity estimation but it affected SNR for all methods. The Richardson 4* method and its compact version were the most accurate and stable methods for vorticity magnitude evaluation. Vorticity field determination using the eight-point circulation method, the most common method used in CMR, has reduced accuracy compared to other vorticity schemes. Richardson 4* and its compact version showed stable SNR using both theoretical and in vivo data.


Open Heart | 2018

Prevalence of left ventricle non-compaction criteria in adult patients with bicuspid aortic valve versus healthy control subjects

Mylène Shen; R. Capoulade; Lionel Tastet; Ezequiel Guzzetti; Marie-Annick Clavel; Erwan Salaun; Elisabeth Bédard; Marie Arsenault; Philippe Chetaille; Helena Tizon-Marcos; Florent Le Ven; Philippe Pibarot; Eric Larose

Objective The aim of this study was to compare the prevalence of left ventricle non-compaction (LVNC) criteria (or hypertrabeculation) in a cohort of patients with bicuspid aortic valve (BAV) and healthy control subjects (CTL) without cardiovascular disease using cardiovascular MR (CMR). Methods 79 patients with BAV and 85 CTL with tricuspid aortic valve and free of known cardiovascular disease underwent CMR to evaluate the presence of LVNC criteria. The left ventricle was assessed at end-systole and end-diastole, in the short-axis, two-chamber and four-chamber views and divided into the 16 standardised myocardial segments. LVNC was assessed using the non-compacted/compacted (NC/C) myocardium ratio and was considered to be present if at least one of the myocardial segments had a NC/C ratio superior to the cut-off values defined in previous studies: Jenni et al (>2.0 end-systole); Petersen et al (>2.3 end-diastole); or Fazio et al (>2.5 end-diastole). Results 15 CTL (17.6%) vs 8 BAV (10.1%) fulfilled Jenni et al’s criterion; 69 CTL (81.2%) vs 49 BAV (62.0%) fulfilled Petersen et al’s criterion; and 66 CTL (77.6%) vs 43 BAV (54.4%) fulfilled Fazio et al’s criterion. Petersen et al and Fazio et al’s LVNC criteria were met more often by CTL (p=0.006u2009and p=0.002, respectively) than patients with BAV, whereas this difference was not statistically significant according to Jenni et al’s criterion (p=0.17). In multivariable analyses, after adjusting for age, sex, the presence of significant valve dysfunction (>mild stenosis or >mild regurgitation), indexed LV mass, indexed LV end-diastolic volume and LV ejection fraction, BAV was not associated with any of the three LVNC criteria. Conclusion Patients with BAV do not harbour more LVNC than the general population and there is no evidence that they are at higher risk for the development of LVNC cardiomyopathy.


XIII MEXICAN SYMPOSIUM ON MEDICAL PHYSICS | 2014

Valve morphology effect in aortic coarctation flow using realistic silicon models and magnetic resonance imaging

Oscar Marrufo; Sergio Solis-Najera; Philippe Pibarot; Lyes Kadem; Zahra Kesharvarz-Motamed; A. O. Rodriguez; Julio Garcia

Aortic valve morphology and phenotype may alter the aortic wall structure and its normal flow hemodynamics. However, the relationship between altered flow patterns and progression of wall pathology is often not fully understood in patients with aortic coartation and needs larger experimental work. In this study, we introduced a compatible experimental setup with magnetic resonance imaging (MRI) using a realistic aortic coarctation (AoCo) silicon model which can replicate physiological flow conditions (pressure, flow-wave, and systemic load). We evaluated the aortic valve hemodynamics of a normal tricuspid valve and a stenotic bicuspid valve using valve effective orifice area (EOA), peak and mean transvalvular pressure gradient (TPG). AoCo severity was assessed by the AoCo pressure gradient. For the tricuspid valve we obtained an EOA = 1.89 cm2, a peak TPG = 10 mmHg, and a mean TPG = 5 mmHg. For the bicuspid valve we obtained an EOA = 1.03 cm2, a peak TPG = 37 mmHg and a mean TPG = 13 mmHg. Furthermore, Ao...


Archive | 2014

Structural and Hemodynamic Integrity of the Implanted TAVR Valve

Philippe Pibarot; Rebecca T. Hahn; Jean G. Dumesnil

Careful follow-up of prosthetic valve position, morphology, and function after transcatheter aortic valve replacement (TAVR) is key for early detection and optimal management of complications. The purpose of this chapter is to provide an overview of the current state of knowledge and future perspectives with regard to the role of multimodality imaging in the evaluation of the structural and hemodynamic integrity of the implanted transcatheter heart valve (THV). The goals of post-implant imaging are the following: (1) structural evaluation, including assessment of valve stent deployment and position and of valve cusps morphology and mobility; (2) functional evaluation including measurement of transprosthetic gradients, valve effective orifice area (EOA), and Doppler velocity index, and quantification of valvular an paravalvular regurgitation; and (3) detection of late complications such as migration of the prosthesis, formation of pannus or thrombus, impingement of the mitral valve, perforation of the ventricular septum, and endocarditis.


European Heart Journal | 2013

Resting level of plasma brain natriuretic peptide and response to exercise as predictors of outcomes in asymptomatic patients with aortic stenosis

R. Capoulade; Julien Magne; Raluca Dulgheru; Zeineb Hachicha; Jean G. Dumesnil; Kim O'Connor; Marie Arsenault; Luc Pierard; Patrizio Lancellotti; Philippe Pibarot

Purpose: Exercise stress echocardiography is useful in the management and risk stratification of patients with asymptomatic aortic stenosis (AS). Resting brain natriuretic peptides (BNP) level is associated with increased risk of adverse events in AS patients. The incremental prognostic value of BNP response during exercise is unknown. The objectives of this study were to assess the correlates of the plasma level of BNP during exercise as well as its usefulness to predict outcomes in asymptomatic patients with AS.nnMethods: Resting and exercise Doppler-echocardiographic data and BNP levels were prospectively collected in 211 asymptomatic AS patients in 2 centers.nnResults: Plasma BNP level increased significantly from rest to exercise (65±86 to 91±111 pg/mL, p 43 pg/mL; median value).nnConclusion: This study reports that, in asymptomatic patients with AS, peak-exercise BNP level provides important incremental prognostic value beyond what is achieved by demographic and echocardiographic data, as well as resting BNP level. These findings lend support to the measurement of BNP during exercise to enhance risk stratification in asymptomatic AS.


Canadian Journal of Cardiology | 2012

583 Prognostic Value of BNP Level During Exercise in Asymptomatic Patients With Aortic Stenosis

R. Capoulade; Z. Hachicha; Marie-Annick Clavel; Abdellaziz Dahou; Jean G. Dumesnil; Marie Arsenault; Kim O'Connor; Elisabeth Bédard; F. Le Ven; Patrick Mathieu; Philippe Pibarot

patients with and without events are shown in the Table. Multivariate analysis showed that peak AS velocity (HR 1.076, p 0.0001) and log BNP (HR 1.501, p 0.0082) were independent predictors of outcome, whereas age, aortic valve calcification, and LDL cholesterol were not. CONCLUSION: In mild to moderate AS, AS severity and BNP are predictors of outcome. Thus, more vigilant followup should be given to patients with moderate AS and/or high BNP levels. Measurement of BNP appears to complement echocardiographic assessment in the management of AS patients. Further studies should be conducted to evaluate the role of BNP.

Collaboration


Dive into the Philippe Pibarot's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge